Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.76 EUR | -4.97% | +2.52% | -54.14% |
May. 14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
May. 14 | Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease | CI |
Evolution of the average Target Price on Evotec SE
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Evotec SE
WARBURG RESEARCH | Christian Ehmann |
RBC | Charles Weston |
DEUTSCHE BANK RESEARCH | Falko Friedrichs |
JEFFERIES | Benjamin Jackson |
MORGAN STANLEY | James Quigley |
BERENBERG | Gerhard Orgonas |
DEUTSCHE BANK | Falko Friedrichs |
BAADER BANK | Bruno Bulic |
EPS Revisions
- Stock Market
- Equities
- EVT Stock
- Consensus Evotec SE